ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 265875 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 265875; 2) Community: the network communities that were significantly associated with the response to NSC 265875; 3) Molecule: the relationships between components within communities and NSC 265875; 4) MDR: the compounds that were significantly associated with the NSC 265875.

NSC Compound Enrichment Correlation
NSC 746351 Null 0.0285477013888569 0.26213055
NSC 747459 Null 0.0285477013888569 0.08554533
NSC 752503 2,7-Bis-[2-(3,4,5-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone dipara-toluensulfonate dihydrate salt 0.0285477013888569 0.5099353
NSC 753188 4-chloro-N-(4-(3-(4-chloro-3-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide 0.0285477013888569 0.14770714
NSC 756188 GSK718429A 0.0285477013888569 0.23193093
NSC 758671 ANCITABINE HYDROCHLORIDE 0.0285477013888569 0.06529084
NSC 759018 Null 0.0285477013888569 -0.072415237
NSC 87221 Actinomycin D, 2A-D-alloisoleucine- (9CI) 0.0285477013888569 0.46986247
NSC 123138 Alanine, 3-[(p-chloro-.alpha.,.alpha.-diphenylbenzyl)thio]-, L- (8CI) 0.0303734648501639 0.34517531
NSC 123140 Alanine, 3-[(.alpha.,.alpha.-di-p-tolylbenzyl)thio]- 0.0303734648501639 0.27084001
Total:86  Current:59    [First] [Prev] [Next] [Last]